MedPath

DEFERASIROX (TYPE J)

DEFERASIROX (TYPE J)

Approved
DIN Number

02527340

Drug Class

Human

Market Date

N/A

Company
HC

JUBILANT GENERICS LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02527340
AIG Number0151733004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC03 DEFERASIROX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification64:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEFERASIROXActive
Strength: 90 MG
Monograph: DEFERASIROX

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.